Small Cap Feast
Small Cap Feast – 16 July 2019
Set Menu AIM:
Total number of AIM Companies (Incl Susp): 888
Total number of AIM Companies trading: 807*
* As at 15 July 2019
Set Menu NEX Growth:
Total number of NEX Growth Market Companies (Incl Susp): 88*
Total number of NEX Growth Market Companies trading: 86*
* As at 15 July 2019
Set Menu Standard List:
Total number of Standard List Companies (Incl Susp): 165*
Total number of Standard List Companies trading: 143*
* As at 15 July 2019
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
What’s Cooking in the IPO Kitchen?
Main Market (Premium)
Main Market (Specialist Funds)
Voyager AIR The Company will focus on the acquisition, leasing and management of primarily widebody aircraft, with asset management services to be provided by Amedeo Limited the IPO will comprise a Placing and Offer for Subscription of Shares to raise up to approximately US$200m.
Uniphar, a diversified healthcare services business with a workforce of over 2,000, is looking to join AIM. Raising EUR135m with market cap on admission of EUR309.6m, expected 17 July 2019.
Roxi Music UK music streaming service plans London IPO as it goes up against Spotify. They have appointed investment bank Arden Partners for an initial public offering (IPO) on the London Stock Exchange later this year.
Cloudcall Group PLC (CALL) 119p £31.68m
CloudCall, a leading cloud-based software business that integrates communications technology with Customer Relationship Management (CRM) platforms, announces the following trading update for the six months ended 30 June 2019:
Revenue up 30% vs H1 2018 with recurring revenue up 34%
Users up 37% vs H1 2018 to just under 37,000
New orders received up 44% vs H1 2018, including the Company’s first large enterprise deal
In Q2, monthly net user growth exceeded the stated target of 1,000 per month
US revenues now 40% of global recurring revenue
US operations profitable and generating cash
Terms agreed on a new £3m debt facility with Shawbrook Bank to replace current facility
Available cash resources of £4.5m through a combination of its own cash, its new credit facility and its expected R&D tax credit
Revenues for the six-month period were approximately £5.2m, an increase of 30% against H1 2018, and recurring revenues up by 34% compared to the same period. Churn remains low and factoring in upsells, net renewal rates from existing customers remain above 100%, helping to drive revenue and user growth.
Blackbird PLC (BIRD) 6.8p £20m
Blackbird, the developer and seller of the market-leading cloud video platform Blackbird, has announced that TownNews has extended its adoption of Blackbird for the rapid production of digital news content. This is the third such deployment within a year.
TownNews has added an additional 14 TV stations that will use Blackbird – bringing the total to 39 stations in 24 states. The additional stations are owned by seven broadcast groups that provide premium local news content to millions of viewers across the United States.
Blackbird enables TownNews’ partners to rapidly view, edit and publish video content no matter their location. When paired with the TownNews Field59 VMS, news stories can be delivered with unprecedented speed and control using Blackbird’s browser-based cloud video platform.
Local TV news networks in the US comprise over 350 stations producing around six hours of news content per weekday. The industry as a whole generates nearly $28bn of revenue annually. The move to the consumption of digital news has been rapid with 43% of US adults now often sourcing news from websites and social media.
ABCAM PLC (ABC) 1,361p £2,799m
Abcam, a global innovator in life science reagents and tools, announced the acquisition of the entire live cell line and lysates portfolio of EdiGene Inc, a leading company focused on developing genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery.
Using their proprietary high-throughput cell editing platform, EdiGene developed the industry’s largest off-the shelf diploid library of over 2,800 single clonal knockout (KO) cell lines targeting over 2,600 genes in commonly used human cancer cell lines (including HeLa, HEK293-T, A549, HCT116, Hep G2 and MCF7).
Ready-made diploid KO cell lines are an important tool for antibody validation. They also play a significant role in the study and understanding of biological pathways and disease models and can be used in screening and cellular assays. EdiGene’s cell lines and lysates are used by top academic researchers, global biopharmaceutical companies, and leading antibody companies.
Financial terms of the transaction have not been disclosed and are expected to have a minimal impact on revenue and earnings in the current financial year.
Karelian Diamonds* (KDR) 3.35p £1.16m
Karelian Diamonds announced the appointment of Mr Howard Bird as consultant to the Company. The Company intends to appoint Mr. Bird to its Board at an appropriate later date.
Mr. Bird is an internationally experienced Professional Geoscientist and has over 30 years’ diverse junior and senior mining company exploration, development and mining experience, including over 15 years at senior executive management level.
Mr. Bird has a strong background in both European and North American marketing, capital financings, mergers and acquisitions, and joint-ventures. He has a proven track record contributing to significant company value added growth with grassroots exploration discovery success, development and production of highly profitable kimberlite diamond deposits.
The Company also announced that it has conditionally raised £0.1m, through a subscription of a total of 2,500,000 new ordinary shares of €0.00025 each in the capital of the Company, at a price of 4p per Subscription Share. The Subscription Shares have been subscribed for by a new investor, Martello Holdings Limited.
The Subscription Price represents a premium of approximately 31% to the closing mid-market price of 3.05p per Ordinary Share on 12 July 2019. The net proceeds of the Subscription will be applied for general working capital purposes.
Everyman Media Grp (EMAN) 182.5p £132m
Everyman Media provide the following trading update for the 26 weeks ended 4 July 2019.
The Group ended the period operating 28 cinemas having opened a three-screen venue in Horsham and a four-screen venue in Newcastle during the period. Demand for the Everyman offer continues to strengthen, and the Board announced that new contracts have recently been exchanged for a new venue in Egham, Surrey (four screens). The Company is on track to open five more new venues in 2019 and has legal commitments to open a further nine sites through 2020 and 2021 with more in advanced stages of negotiation.
The Group has performed in line with expectations in the first 26 weeks of 2019 and the Board is confident of a successful outcome for the full year. The Group intends to publish its interim results for the 26 weeks ended 4 July 2019 on 24 Sept 2019.
Big Sofa Tech. Grp. (BST) 4.55p £7.45m
Big Sofa Technologies announced a further service agreement with a global technology company based on the West Coast of the US for its proprietary, video-based collaboration system, along with an initial commission under that service agreement.
This service agreement is the second such agreement with a US based global technology company in the past 4 months, the first having been announced in March 2019. Both companies have now commissioned introductory projects under their respective service agreements, with an overall initial aggregate value of over $100k. These commissions mark further progress against the Company’s objective of extending beyond retail and consumer packaged goods into the technology and digital sectors.
Surface Transforms (SCE) 19.5p £26.5m
Surface Transforms announced that it has been notified of its selection as a tier one supplier of a carbon ceramic brake disc to a major German automotive company – previously described by Surface Transforms as “OEM 5”.
Pursuant to this selection, Surface Transforms has received an order for the production tooling. The final stage of the selection process is the signing of a master purchase agreement which is anticipated to take approximately 4-8 weeks to finalise. However, the principal commercial terms are already agreed.
Specifically, the selection is for Surface Transforms to be the sole supplier of the carbon ceramic brake disc option on one axle of a new edition of an existing well-known model of German OEM 5. The existing model already uses carbon ceramic discs as an option and therefore the forecast production volumes reflect this experience. The lifetime revenue on this specific car model contract is estimated to be approximately €11.8m commencing in October 2021. Annual revenue is estimated to be approximately €2m per year before tapering off during 2026.
Zegona Comm PLC (ZEG) 104.50p £231m
Zegona provided an update on the operational improvements at Euskaltel, following the appointment of José Miguel García as CEO and the appointment of two key Zegona executives as proprietary directors. Earlier this year, Zegona significantly increased its ownership stake in Euskaltel and is now its largest shareholder.
José Miguel García was appointed as CEO of Euskaltel Group by the Board of Directors with unanimous agreement on 5 June 2019, and his appointment was overwhelmingly endorsed by shareholders at the Extraordinary Shareholder Meeting on 10 July 2019. At the same shareholder meeting, Zegona’s Chief Executive Officer Eamonn O’Hare and Chief Operating Officer Robert Samuelson were also approved as proprietary directors on Euskaltel’s Board.
In his first month as CEO, José Miguel has made a fast start with significant progress in implementing a new plan for the business.
Science Group PLC (SAG) 199p £81.8m
Science Group announced that on 15 July 2019 the Company purchased 377,807 shares in the capital of Frontier at a price of 35p per share. Following these purchases, the Company holds a total of 15,272,320 shares in the capital of Frontier, equivalent to 37.5%of the voting share capital of Frontier.
Fulham Shore PLC (FUL) 11.5p £65.71m
Fulham Shore announced its proposed acquisition, subject to shareholder approval, of the approximately 1% minority interests in two of its subsidiaries: Kefi Limited (“Kefi”), which owns the subsidiary that owns and operates The Real Greek restaurants; and Franco Manca Holdings Limited (formerly Rocca Limited), which owns the subsidiary that owns and and operates the Franco Manca pizzeria, for a total consideration of up to £650,658, payable in cash.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email email@example.com with “unsubscribe me”.